# Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

> **NCT00890435** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 53 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Leukemia
- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **OTHER:** questionnaire administration
- **PROCEDURE:** psychosocial assessment and care

## Key facts

- **NCT ID:** NCT00890435
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-08
- **Final completion:** 2011-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890435, "Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00890435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*